Accreditation Information

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.

Type of Activity
Live Activity
Application

Educational Objectives

At the conclusion of this activity, all participants should be able to:

  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team;

Session I: Unveiling Lipoprotein(a): Hidden Culprit in Cardiovascular Disease

  • Discuss the role of lipoprotein(a) (Lp(a)) in risk assessment and management of cardiovascular disease (CVD).
  • Assess the potential of new and emerging therapeutic options to manage Lp(a).
  • Identify risk enhancing factors that might impact the care of patients with elevated Lp(a).
  • Recognize population differences that may impact clinical care.

Session II: Inflammation – Everything Old is New Again

  • Discuss recent and ongoing clinical trials involving the effect of inflammation on atherosclerotic cardiovascular disease.
  • Describe the use of anti-inflammatory agents in treatment of cardiovascular disease.
  • Recognize unique challenges for the management of cardiovascular disease in patients with HIV.

Session III:  TG and ASCVD – Do TGs Cause Heart Disease?

  • Describe role of triglycerides in lipoprotein physiology and vascular biology.
  • Discuss the genetics of triglyceride disorders and the epidemiology of triglyceride-containing lipoproteins and atherosclerotic cardiovascular disease.
  • Discuss recent clinical trials of lipid-modifying therapies.

Session IV: Top Editor Picked JCL Publications 

  • Review the practical application of recent publications to the clinical evaluation and management of patients with dyslipidemia.

Session V: Fireside Chat – What Should I Eat?

  • Discuss the impact of proper dietary education in patient care.

Session VI: Obesity – How Science Can Inform Clinical Compassion

  • Identify the impact of appropriate dietary education for diverse populations.
  • Recognize the role of drug therapy in the management of obesity.
  • Implement strategies for weight management in practice. 

Session VII: Genetics – Is Our Destiny Written?

  • Explain the role of genetics in inherited lipid disorders.
  • Discuss how genetics can inform the management of severe hypertriglyceridemia.
  • Evaluate the possible benefits of screening for genetic markers for the early detection and prevention in coronary artery disease.

Session VIII: Addressing Cardiometabolic Challenges in the American Indian Population

  • Discuss unique challenges managing dyslipidemia in special populations.

Session VIIII: Lifespan – Lifelong Condition, Lifelong Attention

  • Discuss how to evaluate and manage patients across the lifespan.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.75 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

DietitiansThe National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 12.75 continuing professional education units (CPEUs) for completion of this program/ materials. Completion of this RD/DTR profession-specific of IPCE activity awards CPEUs (One IPCE credit = One CPEU).

Pharmacist Accreditation Statement

Universal Activity Number JA0007192-0000-23-028-L01-P (Application)
This Activity has been approved for 12.75 contact hour(s) (1.275 CEUs) of the Accreditation Council for Pharmacy Education

Nursing
The maximum number of hours awarded for this CE activity is 12.75 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

 

Criteria for Success:
Statements of credit will be awarded based on the participant´s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme.
For Pharmacists: Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
For Dietitians: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities / materials by CDR.

Disclosure Statement:
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity.

Commercial Support:
Full notification of commercial support will be provided in the activity materials.